Davis Barbara J, Haneke Karen E, Miner Kelly, Kowalik Ania, Barrett J Carl, Peddada Shyamal, Baird Donna Day
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
J Womens Health (Larchmt). 2009 May;18(5):725-32. doi: 10.1089/jwh.2008.0903.
The demographics, ethnicity, symptoms, lifestyle characteristics, and treatment outcomes are analyzed in participants of a study designed to evaluate uterine leiomyoma growth and correlate symptoms and outcomes in a clinically relevant population of women (Fibroid Growth Study).
Women included in the Fibroid Growth Study (FGS) completed a medical history and physical examination, underwent T1-weighted and T2-weighted magnetic resonance image (MRI) scans, provided urine and blood samples at each scheduled MRI, and responded to an initial extensive telephone-administered questionnaire followed by abbreviated monthly questionnaire updates. Summary scores were developed to quantify stress, pain, and bleeding. The Wilcoxin test was used for statistical comparisons between study participant characteristics and tumor-related characteristics.
Participants included 116 premenopausal women, ranging in age from 20 to 54 years; 48% were black women, 41% were white women, 10% were women of other or multiple racial backgrounds, and 1% did not self-identify. Over 90% of participants had multiple leiomyomas, and nearly a third had more than 10. Black women were younger and had more fibroids, but no differences were found in the proportions of black and white women choosing an intervention; 44% of black women and 40% of white women chose intervention during the study.
There was no correlation between number of leiomyomas or uterine size and choosing treatment. However, women who opted for treatment were more symptomatic, with higher bleeding and pain scores, compared with the women with no intervention. Consequently, our study suggests that once women are symptomatic, black and white women choose surgery as a treatment method for the same reasons and at about the same rates. Moreover, our data suggest that bleeding and pain, not the size or multiplicity of fibroids, determine the choice for intervention. Therefore, aggressive management of pain and bleeding may be effective in reducing the need for surgical intervention.
在一项旨在评估子宫平滑肌瘤生长情况并关联症状与结局的临床相关女性人群研究(肌瘤生长研究)的参与者中,分析其人口统计学特征、种族、症状、生活方式特点及治疗结局。
纳入肌瘤生长研究(FGS)的女性完成病史采集和体格检查,接受T1加权和T2加权磁共振成像(MRI)扫描,在每次预定的MRI检查时提供尿液和血液样本,并回答一份初始的广泛电话调查问卷,随后每月进行简短问卷更新。制定了汇总评分以量化压力、疼痛和出血情况。采用Wilcoxin检验对研究参与者特征与肿瘤相关特征进行统计学比较。
参与者包括116名绝经前女性,年龄在20至54岁之间;48%为黑人女性,41%为白人女性,10%为其他或多种种族背景的女性,1%未表明自己的种族。超过90%的参与者有多个平滑肌瘤,近三分之一的参与者有10个以上。黑人女性更年轻且肌瘤更多,但在选择干预措施的黑人女性和白人女性比例上未发现差异;44%的黑人女性和40%的白人女性在研究期间选择了干预措施。
平滑肌瘤数量或子宫大小与选择治疗之间无相关性。然而,与未接受干预的女性相比,选择治疗的女性症状更明显,出血和疼痛评分更高。因此,我们的研究表明,一旦女性出现症状,黑人和白人女性选择手术作为治疗方法的原因相同且比例相近。此外,我们的数据表明,出血和疼痛而非肌瘤的大小或数量决定了干预的选择。因此,积极处理疼痛和出血可能有效减少手术干预的需求。